Raymond James Financial
ONC

Raymond James Financial’s BeOne Medicines Ltd ONC Stock Holding History

Raymond James Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78M Buy
20,273
+1,226
+6% +$361K ﹤0.01% 2620
2026
Q1 		$5.66M Buy
19,047
+1,492
+8% +$483K ﹤0.01% 2488
2025
Q4 		$5.33M Buy
17,555
+359
+2% +$118K ﹤0.01% 2459
2025
Q3 		$5.86M Buy
17,196
+693
+4% +$210K ﹤0.01% 2353
2025
Q2 		$3.99M Buy
16,503
+472
+3% +$116K ﹤0.01% 2528
2025
Q1 		$4.36M Buy
16,031
+862
+6% +$202K ﹤0.01% 2428
2024
Q4 		$2.8M Buy
+15,169
New +$3.1M ﹤0.01% 2718

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Raymond James Financial's ONC Position: Q2 2026 in Review

Raymond James Financial increased its BeOne Medicines Ltd (ONC) stake by 6.4% in Q2 2026, buying an estimated $361K and bringing the position to 20,273 shares worth $5.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Raymond James Financial first reported a position in ONC in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.86M in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Raymond James Financial held 20,273 shares of BeOne Medicines Ltd worth $5.78M as of Q2 2026.
  • Raymond James Financial bought 1,226 BeOne Medicines Ltd shares in Q2 2026, an estimated $361K.
  • BeOne Medicines Ltd made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2620 holding.
  • Raymond James Financial first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's BeOne Medicines Ltd position peaked at $5.86M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.